ArticleClinical kidney journal2025

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Maxime Teisseyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.